We suggest a model whereby cell–cell contact with immune cells and the presence of pro-inflammatory cytokines and HMGB1 in the joints of RA patients promote Amigo2 expression in an ERK-dependent manner and enhance their resistance to apoptosis (Figure 6). The gene discussed is HMGB1; the disease is rheumatoid arthritis.